Immediate Impact
3 from Science/Nature 70 standout
Citing Papers
Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients
2023 Standout
β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway
2020 Standout
Works of G. A. Levy being referenced
CLINICAL UTILITY OF QUANTITATIVE CYTOMEGALOVIRUS VIRAL LOAD DETERMINATION FOR PREDICTING CYTOMEGALOVIRUS DISEASE IN LIVER TRANSPLANT RECIPIENTS1
1999
Resistance of Naive Mice to Murine Hepatitis Virus Strain 3 Requires Development of a Th1, but not a Th2, Response, Whereas Pre-Existing Antibody Partially Protects Against Primary Infection
1998
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| G. A. Levy | 189 | 20 | 44 | 64 | 60 | 12 | 362 | |
| Ana Strezova | 80 | 4 | 119 | 44 | 58 | 24 | 361 | |
| Laura Marbello | 137 | 6 | 27 | 121 | 103 | 19 | 375 | |
| Roberto Castronari | 137 | 67 | 87 | 19 | 12 | 335 | ||
| J. P. O'Malley | 61 | 1 | 67 | 16 | 153 | 11 | 349 | |
| Lynda Bererhi | 49 | 72 | 32 | 158 | 11 | 13 | 368 | |
| Harvey G. Klein | 66 | 38 | 27 | 117 | 11 | 357 | ||
| Dale M. Selby | 90 | 56 | 90 | 13 | 14 | 350 | ||
| Julian B. Schorr | 82 | 2 | 36 | 94 | 119 | 17 | 379 | |
| E. A. M. Sanders | 173 | 11 | 121 | 36 | 59 | 18 | 405 | |
| Franziska Scherer | 53 | 9 | 180 | 54 | 97 | 8 | 405 |
All Works
Loading papers...